Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Market Closed - BME 11:38:40 2026-09-04 am EDT			5-day change	1st Jan Change
59.30 ^EUR	-0.42%		-2.55%	-6.61%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.52B		BBB
ELI LILLY AND COMPANY	1,024B		A
JOHNSON & JOHNSON	663B	-	BBB	-	-
ABBVIE INC.	453B		AA		-
ROCHE HOLDING AG	352B		AA
NOVARTIS AG	304B		AAA
ASTRAZENECA PLC	252B		A
AMGEN INC.	236B		A
NOVO NORDISK A/S	206B		A
GILEAD SCIENCES, INC.	187B		AA
PFIZER INC.	162B		A
VERTEX PHARMACEUTICALS INCORPORATED	138B		AA
BRISTOL-MYERS SQUIBB COMPANY	136B		A
SANOFI	106B		AA
GSK PLC	100B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	71.64B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	58.86B		AA
BAYER AG	55.77B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	45.14B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	42.37B		-
Average	229.95B		AA
Weighted average by Cap.			AA